We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Outlines Statistical Methods for Clinical Trials with Multiple Endpoints
FDA Outlines Statistical Methods for Clinical Trials with Multiple Endpoints
The FDA issued a draft guidance urging sponsors to work to control error rates before launching clinical trials with multiple endpoints, and provided several examples of appropriate statistical methods.